{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T18:55:53Z","timestamp":1784919353333,"version":"3.55.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s12350-018-01488-9","type":"journal-article","created":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T12:03:16Z","timestamp":1541160196000},"page":"188-199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Advanced cardiovascular imaging for the evaluation of cardiac sarcoidosis"],"prefix":"10.1016","volume":"26","author":[{"given":"Paco E.","family":"Bravo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amitoj","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo F.","family":"Di Carli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Blankstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s12350-018-01488-9_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-195202000-00001","article-title":"A study of sarcoidosis; based on a combined investigation of 160 cases including 30 autopsies from The Johns Hopkins Hospital and Massachusetts General Hospital","volume":"31","author":"Longcope","year":"1952","journal-title":"Medicine (Baltim)"},{"key":"10.1007\/s12350-018-01488-9_bib2","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/01.CIR.58.6.1204","article-title":"Cardiac sarcoid: A clinicopathologic study of 84 unselected patients with systemic sarcoidosis","volume":"58","author":"Silverman","year":"1978","journal-title":"Circulation"},{"key":"10.1007\/s12350-018-01488-9_bib3","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1378\/chest.103.1.253","article-title":"Myocardial sarcoidosis","volume":"103","author":"Sharma","year":"1993","journal-title":"Chest"},{"key":"10.1007\/s12350-018-01488-9_bib4","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1749-6632.1976.tb47058.x","article-title":"Clinicopathological study of fatal myocardial sarcoidosis","volume":"278","author":"Matsui","year":"1976","journal-title":"Ann NY Acad Sci"},{"key":"10.1007\/s12350-018-01488-9_bib5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/CRD.0b013e3181a1f763","article-title":"Cardiac manifestations of sarcoidosis and therapeutic options","volume":"17","author":"Pierre-Louis","year":"2009","journal-title":"Cardiol Rev"},{"key":"10.1007\/s12350-018-01488-9_bib6","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0002-9343(77)90121-8","article-title":"Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11)","volume":"63","author":"Roberts","year":"1977","journal-title":"Am J Med"},{"key":"10.1007\/s12350-018-01488-9_bib7","first-page":"e350","volume":"117","author":"Epstein","year":"2008","journal-title":"Circulation"},{"key":"10.1007\/s12350-018-01488-9_bib8","first-page":"347","article-title":"Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis","volume":"15","author":"Kron","year":"2013","journal-title":"Europace Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol"},{"key":"10.1007\/s12350-018-01488-9_bib9","first-page":"210","article-title":"National survey on status of steroid therapy for cardiac sarcoidosis in Japan","volume":"22","author":"Hiramitsu","year":"2005","journal-title":"Sarcoidosis Vasc Diffus Lung Dis"},{"key":"10.1007\/s12350-018-01488-9_bib10","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm Off J Heart Rhythm Soc"},{"key":"10.1007\/s12350-018-01488-9_bib11","first-page":"1741","article-title":"Joint SNMMI-ASNC expert consensus document on the role of (18)F-FDG PET\/CT in cardiac sarcoid detection and therapy monitoring","volume":"24","author":"Chareonthaitawee","year":"2017","journal-title":"J Nucl Cardiol Off Publ Am Soc Nucl Cardiol"},{"key":"10.1007\/s12350-018-01488-9_bib12","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/ehjci\/jex146","volume":"18","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1007\/s12350-018-01488-9_bib13","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0002-8703(99)70115-8","article-title":"Histologic diagnostic rate of cardiac sarcoidosis: Evaluation of endomyocardial biopsies","volume":"138","author":"Uemura","year":"1999","journal-title":"Am Heart J"},{"key":"10.1007\/s12350-018-01488-9_bib14","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1056\/NEJMra071714","article-title":"Sarcoidosis","volume":"357","author":"Iannuzzi","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1007\/s12350-018-01488-9_bib15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0735-1097(92)90049-S","article-title":"Complications of transvenous right ventricular endomyocardial biopsy in adult patients with cardiomyopathy: A seven-year survey of 546 consecutive diagnostic procedures in a tertiary referral center","volume":"19","author":"Deckers","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-018-01488-9_bib16","first-page":"1989","article-title":"Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis","volume":"45","author":"Okumura","year":"2004","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"key":"10.1007\/s12350-018-01488-9_bib17","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jcmg.2012.10.021","article-title":"CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis","volume":"6","author":"Greulich","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1007\/s12350-018-01488-9_bib18","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.amjcard.2009.03.068","article-title":"Comparison of necropsy findings in patients with sarcoidosis dying suddenly from cardiac sarcoidosis versus dying suddenly from other causes","volume":"104","author":"Tavora","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1007\/s12350-018-01488-9_bib19","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1136\/pgmj.34.391.248","article-title":"The pathology of sarcoidosis","volume":"34","author":"Thomson","year":"1958","journal-title":"Postgrad Med J"},{"key":"10.1007\/s12350-018-01488-9_bib20","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1136\/pgmj.64.753.536","article-title":"Immune aspects of sarcoidosis","volume":"64","author":"Poulter","year":"1988","journal-title":"Postgrad Med J"},{"key":"10.1007\/s12350-018-01488-9_bib21","doi-asserted-by":"crossref","first-page":"iii23","DOI":"10.1093\/ejechocard\/jep156","article-title":"Restrictive cardiomyopathies","volume":"10","author":"Nihoyannopoulos","year":"2009","journal-title":"Eur J Echocardiogr"},{"key":"10.1007\/s12350-018-01488-9_bib22","doi-asserted-by":"crossref","first-page":"E138","DOI":"10.1111\/echo.12536","article-title":"Cardiac sarcoid: A chameleon masquerading as hypertrophic cardiomyopathy and dilated cardiomyopathy in the same patient","volume":"31","author":"Agarwal","year":"2014","journal-title":"Echocardiography"},{"key":"10.1007\/s12350-018-01488-9_bib23","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1136\/heartjnl-2011-300379","article-title":"Sarcoidosis presenting as dilated cardiomyopathy","volume":"97","author":"Adlan","year":"2011","journal-title":"Heart"},{"key":"10.1007\/s12350-018-01488-9_bib24","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/eurjhf\/hfr099","article-title":"Myocardial damage in patients with sarcoidosis and preserved left ventricular systolic function: An observational study","volume":"13","author":"Patel","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1007\/s12350-018-01488-9_bib25","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.amjcard.2013.03.027","article-title":"Predictors of cardiac sarcoidosis using commonly available cardiac studies","volume":"112","author":"Freeman","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1007\/s12350-018-01488-9_bib26","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.jcmg.2016.11.019","article-title":"Complementary role of CMR to conventional screening in the diagnosis and prognosis of cardiac sarcoidosis","volume":"10","author":"Kouranos","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1007\/s12350-018-01488-9_bib27","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1378\/chest.07-2784","article-title":"Cardiac involvement in patients with sarcoidosis: Diagnostic and prognostic value of outpatient testing","volume":"133","author":"Mehta","year":"2008","journal-title":"Chest"},{"key":"10.1007\/s12350-018-01488-9_bib28","first-page":"341","article-title":"Usefulness of 18F-FDG PET for diagnosis of cardiac sarcoidosis","volume":"36","author":"Okumura","year":"1999","journal-title":"Kaku Igaku"},{"key":"10.1007\/s12350-018-01488-9_bib29","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00259-007-0650-8","article-title":"Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis","volume":"35","author":"Ohira","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-018-01488-9_bib30","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.jacc.2005.01.047","article-title":"Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis","volume":"45","author":"Smedema","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-018-01488-9_bib31","first-page":"241","article-title":"The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: A systematic review and metaanalysis including the Ontario experience","volume":"53","author":"Youssef","year":"2012","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"key":"10.1007\/s12350-018-01488-9_bib32","article-title":"Isolated cardiac sarcoidosis: A focused review of an under-recognized entity","author":"Okada","year":"2016","journal-title":"J Nucl Cardiol Off Publ Am Soc Nucl Cardiol"},{"key":"10.1007\/s12350-018-01488-9_bib33","article-title":"Insights into biopsy-proven cardiac sarcoidosis in patients with heart failure","author":"Sperry","year":"2015","journal-title":"J Heart Lung Transplant Off Publ Int Soc Heart Transplant"},{"key":"10.1007\/s12350-018-01488-9_bib34","first-page":"166","article-title":"Reduction in (1)(8)F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis","volume":"21","author":"Osborne","year":"2014","journal-title":"J Nucl Cardiol Off Publ Am Soc Nucl Cardiol"},{"key":"10.1007\/s12350-018-01488-9_bib35","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","article-title":"Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis","volume":"63","author":"Blankstein","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-018-01488-9_bib36","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.hrthm.2015.06.032","article-title":"Comparison of cardiac MRI and 18F-FDG positron emission tomography manifestations and regional response to corticosteroid therapy in newly diagnosed cardiac sarcoidosis with complete heart block","volume":"12","author":"Orii","year":"2015","journal-title":"Heart Rhythm Off J Heart Rhythm Soc"},{"key":"10.1007\/s12350-018-01488-9_bib37","article-title":"Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation","author":"Osborne","year":"2016","journal-title":"J Nucl Cardiol Off Publ Am Soc Nucl Cardiol"},{"key":"10.1007\/s12350-018-01488-9_bib38","first-page":"1020","article-title":"False positive 18F-FDG PET\/CT in cardiac sarcoidosis","volume":"2","author":"Sibille","year":"2015","journal-title":"J Mol Biol Mol Imaging"},{"key":"10.1007\/s12350-018-01488-9_bib39","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1161\/CIRCIMAGING.109.905984","article-title":"Relation between right ventricular function and increased right ventricular [18F]fluorodeoxyglucose accumulation in patients with heart failure","volume":"4","author":"Mielniczuk","year":"2011","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1007\/s12350-018-01488-9_bib40","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ejhf.767","article-title":"Clinical impact of the presence of macrophages in endomyocardial biopsies of patients with dilated cardiomyopathy","volume":"19","author":"Nakayama","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1007\/s12350-018-01488-9_bib41","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1148\/radiol.2511081300","article-title":"Whole-body PET\/CT scanning: Estimation of radiation dose and cancer risk","volume":"251","author":"Huang","year":"2009","journal-title":"Radiology"},{"key":"10.1007\/s12350-018-01488-9_bib42","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1161\/01.CIR.94.12.3318","article-title":"Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction","volume":"94","author":"Kim","year":"1996","journal-title":"Circulation"},{"key":"10.1007\/s12350-018-01488-9_bib43","doi-asserted-by":"crossref","unstructured":"Moraes GL, Higgins CB, Ordovas KG. Delayed enhancement magnetic resonance imaging in nonischemic myocardial disease. J Thorac Imaging 2013;28:84-92; quiz 93-5.","DOI":"10.1097\/RTI.0b013e3182828f89"},{"key":"10.1007\/s12350-018-01488-9_bib44","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.007030","article-title":"Complementary value of cardiac magnetic resonance imaging and positron emission tomography\/computed tomography in the assessment of cardiac sarcoidosis","volume":"11","author":"Vita","year":"2018","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1007\/s12350-018-01488-9_bib45","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1161\/CIRCULATIONAHA.109.851352","article-title":"Detection of myocardial damage in patients with sarcoidosis","volume":"120","author":"Patel","year":"2009","journal-title":"Circulation"},{"key":"10.1007\/s12350-018-01488-9_bib46","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005001","article-title":"Presence of late gadolinium enhancement by cardiac magnetic resonance among patients with suspected cardiac sarcoidosis is associated with adverse cardiovascular prognosis: A systematic review and meta-analysis","volume":"9","author":"Hulten","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1007\/s12350-018-01488-9_bib47","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1532-429X-15-41","article-title":"Cardiovascular magnetic resonance artefacts","volume":"15","author":"Ferreira","year":"2013","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1007\/s12350-018-01488-9_bib48","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.113.000867","article-title":"Evaluation of known or suspected cardiac sarcoidosis","volume":"9","author":"Blankstein","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1007\/s12350-018-01488-9_bib49","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.berh.2012.07.008","article-title":"Nephrogenic systemic fibrosis: A systemic fibrosing disease resulting from gadolinium exposure","volume":"26","author":"Bernstein","year":"2012","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1007\/s12350-018-01488-9_bib50","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1164\/rccm.201309-1668LE","article-title":"Improved detection of cardiac sarcoidosis using magnetic resonance with myocardial T2 mapping","volume":"189","author":"Crouser","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1007\/s12350-018-01488-9_bib51","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1136\/jim-2016-000144","article-title":"Resolution of abnormal cardiac MRI T2 signal following immune suppression for cardiac sarcoidosis","volume":"64","author":"Crouser","year":"2016","journal-title":"J Investig Med"},{"key":"10.1007\/s12350-018-01488-9_bib52","article-title":"Hybrid magnetic resonance imaging and positron emission tomography with fluorodeoxyglucose to diagnose active cardiac sarcoidosis","author":"Dweck","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1007\/s12350-018-01488-9_bib53","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ijcard.2017.03.033","article-title":"Risk assessment of patients with clinical manifestations of cardiac sarcoidosis with positron emission tomography and magnetic resonance imaging","volume":"241","author":"Bravo","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1007\/s12350-018-01488-9_bib54","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00259-015-3181-8","article-title":"Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis","volume":"43","author":"Ohira","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-018-01488-9_bib55","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0026-0495(96)90092-X","article-title":"Somatostatin receptor expression in clinical immunology","volume":"45","author":"van Hagen","year":"1996","journal-title":"Metabolism"},{"key":"10.1007\/s12350-018-01488-9_bib56","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1046\/j.1365-2362.1999.00498.x","article-title":"Immunohistochemical localization of somatostatin receptor sst2A in sarcoid granulomas","volume":"29","author":"ten Bokum","year":"1999","journal-title":"Eur J Clin Investig"},{"key":"10.1007\/s12350-018-01488-9_bib57","first-page":"1134","article-title":"Procedure guideline for somatostatin receptor scintigraphy with (111)In-pentetreotide","volume":"42","author":"Balon","year":"2001","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"key":"10.1007\/s12350-018-01488-9_bib58","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1007\/s00259-010-1473-6","article-title":"111In-pentetreotide scintigraphy: Procedure guidelines for tumour imaging","volume":"37","author":"Bombardieri","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-018-01488-9_bib59","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1007\/s002590050297","article-title":"Somatostatin receptor imaging in patients with sarcoidosis","volume":"25","author":"Kwekkeboom","year":"1998","journal-title":"Eur J Nucl Med"},{"key":"10.1007\/s12350-018-01488-9_bib60","first-page":"21","article-title":"Somatostatin receptor scintigraphy and gallium scintigraphy in patients with sarcoidosis","volume":"42","author":"Lebtahi","year":"2001","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"key":"10.1007\/s12350-018-01488-9_bib61","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/BF00173035","article-title":"Somatostatin analogue scintigraphy in granulomatous diseases","volume":"21","author":"Vanhagen","year":"1994","journal-title":"Eur J Nucl Med"},{"key":"10.1007\/s12350-018-01488-9_bib62","doi-asserted-by":"crossref","DOI":"10.1007\/s12149-016-1095-6","article-title":"The utility of PET\/CT with 68Ga-DOTATOC in sarcoidosis: Comparison with 67Ga-scintigraphy","author":"Nobashi","year":"2016","journal-title":"Ann Nucl Med"},{"key":"10.1007\/s12350-018-01488-9_bib63","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijcard.2015.05.073","article-title":"Imaging of myocardial inflammation with somatostatin receptor based PET\/CT\u2014A comparison to cardiac MRI","volume":"194","author":"Lapa","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1007\/s12350-018-01488-9_bib64","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1093\/eurheartj\/ehv278","article-title":"Detection of cardiac sarcoidosis by macrophage-directed somatostatin receptor 2-based positron emission tomography\/computed tomography","volume":"36","author":"Reiter","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1007\/s12350-018-01488-9_bib65","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13550-016-0207-6","article-title":"A dual tracer (68)Ga-DOTANOC PET\/CT and (18)F-FDG PET\/CT pilot study for detection of cardiac sarcoidosis","volume":"6","author":"Gormsen","year":"2016","journal-title":"EJNMMI Res"},{"key":"10.1007\/s12350-018-01488-9_bib66","doi-asserted-by":"crossref","first-page":"e529","DOI":"10.1161\/01.CIR.0000149749.95902.A4","article-title":"Images in cardiovascular medicine. Cardiac sarcoidosis in a patient with hypertrophic cardiomyopathy demonstrated by magnetic resonance imaging and single photon emission computed tomography dual-isotope scintigraphy","volume":"110","author":"Smedema","year":"2004","journal-title":"Circulation"},{"key":"10.1007\/s12350-018-01488-9_bib67","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/3337","article-title":"Imaging proliferation in vivo with [F-18]FLT and positron emission tomography","volume":"4","author":"Shields","year":"1998","journal-title":"Nat Med"},{"key":"10.1007\/s12350-018-01488-9_bib68","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/path.1711390302","article-title":"Application of in vitro techniques to determine proliferation in human sarcoid lymph nodes","volume":"139","author":"van der Gaag","year":"1983","journal-title":"J Pathol"},{"key":"10.1007\/s12350-018-01488-9_bib69","first-page":"135","article-title":"Usefulness of 11C-methionine for differentiating tumors from granulomas in experimental rat models: A comparison with 18F-FDG and 18F-FLT","volume":"49","author":"Zhao","year":"2008","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"key":"10.1007\/s12350-018-01488-9_bib70","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/RLU.0b013e3181c7c149","article-title":"F-18 fluorodeoxyglucose and F-18 fluorothymidine positron emission tomography\/computed tomography imaging in a case of neurosarcoidosis","volume":"35","author":"Kim","year":"2010","journal-title":"Clin Nucl Med"},{"key":"10.1007\/s12350-018-01488-9_bib71","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/RLU.0000000000000653","article-title":"18F-FLT PET imaging in a patient with sarcoidosis with cardiac involvement","volume":"40","author":"Norikane","year":"2015","journal-title":"Clin Nucl Med"},{"key":"10.1007\/s12350-018-01488-9_bib72","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13550-017-0321-0","article-title":"Comparative evaluation of (18)F-FLT and (18)F-FDG for detecting cardiac and extra-cardiac thoracic involvement in patients with newly diagnosed sarcoidosis","volume":"7","author":"Norikane","year":"2017","journal-title":"EJNMMI Res"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12350-018-01488-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-018-01488-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123060889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123060889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-018-01488-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:02:12Z","timestamp":1761026532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358123060889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S1071358123060889"],"URL":"https:\/\/doi.org\/10.1007\/s12350-018-01488-9","relation":{},"ISSN":["1071-3581"],"issn-type":[{"value":"1071-3581","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advanced cardiovascular imaging for the evaluation of cardiac sarcoidosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12350-018-01488-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 American Society of Nuclear Cardiology. Published by ELSEVIER INC. All rights reserved. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}